<< First  < Prev   1   2   3   Next >  Last >> 
  • 2015-02-03 12:00 | Russell Read (Administrator)

    The MUST Research Group, which successfully completed the Multicenter Uveitis Steroid Treatment (MUST) Trial is conducting two new trials, the Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial and the Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy (MERIT) Trial. Both are funded by the National Eye Institute. POINT will compare the relative efficacy of three common approaches for the regional treatment of uveitic macular edema, periocular and intravitreal triamcinolone acetonide, and the dexamethasone intravitreal implant. MERIT will evaluate the relative efficacy of intravitreal ranibizumab and intravitreal methotrexate and the dexamethasone intravitreal implant for the treatment of uveitic macular edema persisting after intravitreal triamcinolone acetonide. The POINT Trial will be initiated in Spring 2015 in clinical centers that are currently following participants in the MUST Trial Follow-up Study and to have new clinical centers selected and preparing for start-up by the time of our Research Group meeting in June 2015. The MERIT Trial will begin approximately 12 months after the start of POINT; the trials will run concurrently until POINT is completed.

    Those interested in being a clinical center for POINT and MERIT should visit the Clinic Applications site or read the attached document to learn more.

  • 2015-01-21 15:56 | Russell Read (Administrator)

    Abstract submission for FOCIS 2015 closes Wednesday, January 15. 

    The American Uveitis Society is a member society of FOCIS, the Federation of Clinical Immunology Societies.

  • 2015-01-20 17:46 | Russell Read (Administrator)

    Interesting application for the iPhone that allows you to help a low vision person with a specific issue via a video/audio link on your iPhone.

    Be My Eyes - iTunes App Store Link

  • 2015-01-16 10:40 | Russell Read (Administrator)

    The American Uveitis Society is proud to reveal its most extensive update to since its inception. This complete revamping will result in enhanced membership customer service by allowing members to view and update their profile information, track their membership status and pay dues online, and provides an enhanced Uveitis Specialist Directory through which patients can easily access clinician contact information.

<< First  < Prev   1   2   3   Next >  Last >> 

Copyright © The American Uveitis Society
All rights reserved

700 18th Street South Suite 601
Birmingham Alabama 35233 USA

The American Uveitis Society is a 501(c)6 non-profit organization

Powered by Wild Apricot Membership Software